Primus In News
Healthtech firms rush for D-Street debut
19-06-2025
Vivek Tandon, Vice President, Primus Partners, shares his view on the recent surge in healthtech IPOs in India. He highlights that the pandemic catalyzed investor interest in digital health infrastructure, paving the way for strong capital market activity in segments like telemedicine, diagnostics, and data-driven healthcare. Initiatives such as e-Sanjeevani and growing private sector innovation have further strengthened the outlook for healthtech companies going public.
Explore Related Insights
- Medicine manufacturing 33 per cent cheaper in India than the US: Ambassador Sandhu
- Retrofitted 9-meter buses are 32.1% more cost-effective than a new EV bus: EGROW and Primus Partners report
- Budget 2025 Expectations Highlights: Govt not considering any structural change in capital gains tax
- Atmanirbhar Bharat Special Part 4
